Suppr超能文献

难民中的多重耐药菌:患病率及其对医院感染控制的影响。

Multidrug-resistant organisms in refugees: prevalences and impact on infection control in hospitals.

作者信息

Heudorf Ursel, Albert-Braun Sabine, Hunfeld Klaus-Peter, Birne Franz-Ulrich, Schulze Jörg, Strobel Klaus, Petscheleit Knut, Kempf Volkhard A J, Brandt Christian

机构信息

Public Health Department, Division of Infectious Diseases and Hygiene, Frankfurt am Main, Germany.

Institute for Laboratory Medicine, Klinikum Frankfurt Höchst, Frankfurt/Main, Germany.

出版信息

GMS Hyg Infect Control. 2016 Aug 9;11:Doc16. doi: 10.3205/dgkh000276. eCollection 2016.

Abstract

INTRODUCTION

The refugee crisis is a great challenge to the social and healthcare system in European countries, especially in Germany. An abundance of data has been published on the refugees' health problems (infections as well as physical diseases and psychiatric problems) and their prevention (i.e., sanitary and vaccination programs). However, data on prevalences of multidrug-resistant organisms (MDRO) in refugees are scarce, although it is known that most refugees are from or travelled through countries with high prevalences of MDRO. This paper presents current data on MDRO colonization of refugees admitted to hospitals, and the impact of screening upon admission and infection control in hospitals is discussed.

METHODS

Anonymous data obtained by screening upon hospital admission were reported by hospitals in the Rhine-Main region of Germany to the local public health department. Screening and microbiological analyses were performed from December 2015 to March 2016 according to standardized and validated methods.

RESULTS

9.8% of the refugees screened (32/325) exhibited colonization with methicillin-resistant Staphylococcus aureus (MRSA), and 23.3% of the refugees (67/290) were colonized with Gram-negative bacteria with extended spectrum beta-lactamases, and/or enterobacteria with resistance against 3 or 4 groups of antibacterials, so-called 3MRGN (multidrug-resistant Gram-negative bacteria with resistance against penicillins, cephalosporins and quinolones) and 4MRGN (with additional resistance against carbapenems). Carbapenem-resistant Gram-negative bacteria (CRGN) were detected in 2.1% (6/290) of the refugees.

CONCLUSION

The data confirms the studies published between 2014 and 2016, encompassing refugees tested in Germany, the Netherlands and Israel, with prevalences of MRSA and CRGN up to 13.5% and 5.6%. The MDRO prevalences are higher than those of "risk groups" for MRSA, such as hemodialysis patients and patients depending on outpatient home-nursing care or residing in nursing homes. Therefore, screening and special infection control in hospitals is strongly suggested when refugees are admitted to hospitals, in order to ensure best medical practice and safety for all hospital patients regardless of their country of origin.

摘要

引言

难民危机对欧洲国家,尤其是德国的社会和医疗体系构成了巨大挑战。关于难民健康问题(感染以及身体疾病和精神问题)及其预防措施(如卫生和疫苗接种计划),已有大量数据发表。然而,尽管已知大多数难民来自或途经耐多药生物体(MDRO)高发国家,但关于难民中MDRO流行情况的数据却很稀少。本文介绍了医院收治难民的MDRO定植现状,并讨论了入院筛查以及医院感染控制的影响。

方法

德国莱茵 - 美因地区的医院将入院筛查获得的匿名数据上报给当地公共卫生部门。2015年12月至2016年3月期间,按照标准化和经过验证的方法进行筛查和微生物分析。

结果

接受筛查的难民中有9.8%(32/325)表现出耐甲氧西林金黄色葡萄球菌(MRSA)定植,23.3%的难民(67/290)被产超广谱β-内酰胺酶的革兰氏阴性菌和/或对3组或4组抗菌药物耐药的肠杆菌定植,即所谓的3MRGN(对青霉素、头孢菌素和喹诺酮耐药的耐多药革兰氏阴性菌)和4MRGN(对碳青霉烯类药物也耐药)。在2.1%(6/290)的难民中检测到耐碳青霉烯类革兰氏阴性菌(CRGN)。

结论

这些数据证实了2014年至2016年期间发表的研究结果,这些研究涵盖了在德国、荷兰和以色列接受检测的难民,MRSA和CRGN的流行率分别高达13.5%和5.6%。MDRO流行率高于MRSA的“风险群体”,如血液透析患者以及依赖门诊家庭护理或居住在养老院的患者。因此,强烈建议在难民入院时在医院进行筛查和采取特殊感染控制措施,以确保所有医院患者无论其原籍国如何都能获得最佳医疗实践和安全保障。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c74/4987489/b752b3078aeb/HIC-11-16-t-001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验